Why the study?
Does candesartan cilexetil reduce major cardiovascular events in elderly patients with mild hypertension?
Population
4,964 male and female patients aged 70-89 years with mild hypertension and a Mini-Mental State Examination…
Comparison
Candesartan cilexetil 8 mg once daily, doubled… vs Matching placebo once daily, doubled to two…
Design
RCT, randomized, parallel-group, double-blind
Follow-up
2 years
Authors
Loading...
The SCOPE study is designed to evaluate whether candesartan cilexetil reduces major cardiovascular events and affects cognitive function in elderly patients with mild hypertension.
Does candesartan cilexetil reduce major cardiovascular events in elderly patients with mild hypertension?
The SCOPE study is designed to evaluate whether candesartan cilexetil reduces major cardiovascular events and affects cognitive function in elderly patients with mild hypertension.
L. Hansson (1999) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: